AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE
申请人:Pharmacia & Upjohn Company LLC
公开号:EP1432707B1
公开(公告)日:2012-03-28
US6455548B2
申请人:——
公开号:US6455548B2
公开(公告)日:2002-09-24
[EN] 4-ALKYL PIPERIDINYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY<br/>[FR] MODULATEURS 4-ALKYL PIPERIDINYL PYRROLIDINE D'ACTIVITE DE RECEPTEUR DE CHEMOKINE
申请人:MERCK & CO INC
公开号:WO2001064216A1
公开(公告)日:2001-09-07
The present invention is directed to pyrrolidine compounds of the formula (I), (wherein R?1, R2, R3, R4c, R4d, and R4f¿ are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-3 and/or CCR-5.